ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Another report demonstrated that Bcr-Abl inhibition by c-Abl specific tyrosine kinase inhibitors (TKIs) induces autophagy, and it hypothesized that autophagy protects CML stem cells, contributing to disease persistence in CML patients.